Hep-CORE: a cross-sectional study of the viral hepatitis policy environment reported by patient groups in 25 European countries in 2016 and 2017-Reference-Cited by-同舟云学术

Hep-CORE: a cross-sectional study of the viral hepatitis policy environment reported by patient groups in 25 European countries in 2016 and 2017

Published:2018-04 Issue: Volume:21 Page:e25052
ISSN:1758-2652
Container-title:Journal of the International AIDS Society
language:en
Short-container-title:J Intern AIDS Soc

Author:

Lazarus Jeffrey V¹²,Stumo Samya R¹,Harris Magdalena³,Hendrickx Greet⁴,Hetherington Kristina L¹,Maticic Mojca⁵⁶,Jauffret-Roustide Marie⁷,Tallada Joan⁸,Simojoki Kaarlo⁹,Reic Tatjana¹⁰,Safreed-Harmon Kelly¹,

Affiliation:

1. Barcelona Institute for Global Health (ISGlobal); Hospital Clínic; University of Barcelona; Barcelona Spain

2. CHIP, Rigshospitalet; University of Copenhagen; Copenhagen Denmark

3. Department of Social and Environmental Health Research; London School of Hygiene and Tropical Medicine; London United Kingdom

4. Viral Hepatitis Prevention Board; Centre for the Evaluation of Vaccination, Vaccine and Infectious Diseases Institute; University of Antwerp; Antwerp Belgium

5. Clinic for Infectious Diseases and Febrile Illnesses; University Medical Centre Ljubljana; Ljubljana Slovenia

6. Faculty of Medicine; University of Ljubljana; Ljubljana Slovenia

7. Cermes3 (Inserm U988 UMR CNRS 8211 EHESS); Paris Descartes University; Paris France

8. European AIDS Treatment Group; Brussels Belgium

9. A-Clinic Foundation; Helsinki Finland

10. European Liver Patients’ Association; Brussels Belgium

Funder

European Liver Patients’ Association

AbbVie

Gilead Sciences

Meso Scale Diagnostics

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Reference34 articles.

1. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013;Stanaway;Lancet,2016

2. World Health Organization Global health sector strategy on viral hepatitis, 2016-2021: towards ending viral hepatitis 2016 http://apps.who.int/iris/bitstream/10665/246177/1/WHO-HIV-2016.06-eng.pdf?ua=1

3. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015;GBD 2015 Mortality and Causes of Death Collaborators;Lancet,2016

4. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide;Perz;J Hepatol,2006

5. The Global Burden of Cancer 2013;Fitzmaurice;JAMA Oncol,2015

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Embedding viral hepatitis into primary healthcare: results of a strategic landscape analysis in Vietnam and the Philippines;The Lancet Regional Health - Western Pacific;2024-03

2. Chronic viral hepatitis C micro‐elimination program using telemedicine in Guigang city;Journal of Viral Hepatitis;2024-02-07

3. Micro-elimination of hepatitis C virus infection in the rural and remote areas of Taiwan – A multi-center collaborative care model;Journal of Microbiology, Immunology and Infection;2023-08

4. Closing the hepatitis C treatment gap: United States strategies to improve retention in care;Journal of Viral Hepatitis;2022-05-26

5. Clinical Evaluation of Plasma Separation Cards as a Tool to Collect, Store, and Test Blood Samples for Hepatitis B and C Serological Markers;Clinical Chemistry;2021-12-30